Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
2009 · BMC Cancer · 161 citations
https://doi.org/10.1186/1471-2407-9-399
Z
Zhenfeng Duan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
163
Papers
9.2K
Citations
55
h-index
116
i10-index
Zhenfeng Duan is an academic researcher from University of Miami. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Drug Transport and Resistance Mechanisms & RNA Interference and Gene Delivery. The author has an h-index of 55, co-authored 139 publications.
ORCID: 0000-0002-8543-083XPapers by this author
worksOleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway
2010 · BMC Cancer · 57 citations
https://doi.org/10.1186/1471-2407-10-187
An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets
2017 · Journal of Hematology & Oncology · 42 citations
https://doi.org/10.1186/s13045-017-0465-4
Guanine nucleotide‐binding protein 1 is one of the key molecules contributing to cancer cell radioresistance
2014 · Cancer Science · 36 citations
https://doi.org/10.1111/cas.12489
Exosomes in the tumor microenvironment of sarcoma: from biological functions to clinical applications
2022 · Journal of Nanobiotechnology · 34 citations
https://doi.org/10.1186/s12951-022-01609-0
A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells
2014 · BMC Cancer · 32 citations
https://doi.org/10.1186/1471-2407-14-681
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat